Agaricus Blazei Murill (ABM) in Patients With Inflammatory Bowel Disease (IBD)

This study has been completed.
Sponsor:
Information provided by:
Oslo University Hospital
ClinicalTrials.gov Identifier:
NCT01106742
First received: March 19, 2009
Last updated: July 18, 2011
Last verified: March 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2011
  Primary Completion Date: July 2011 (Final data collection date for primary outcome measure)